Hemminki A - Search Results

1

Oncolytic viruses for cancer immunotherapy.

Hemminki O, Dos Santos JM, Hemminki A. Hemminki O, et al. Among authors: hemminki a. J Hematol Oncol. 2020 Jun 29;13(1):84. doi: 10.1186/s13045-020-00922-1. J Hematol Oncol. 2020. PMID: 32600470 Free PMC article. Review.

2

Systemic efficacy of oncolytic adenoviruses in imagable orthotopic models of hormone refractory metastatic breast cancer.

Ranki T, Särkioja M, Hakkarainen T, von Smitten K, Kanerva A, Hemminki A. Ranki T, et al. Among authors: hemminki a. Int J Cancer. 2007 Jul 1;121(1):165-74. doi: 10.1002/ijc.22627. Int J Cancer. 2007. PMID: 17315187 Free article.

3

Luciferase imaging for evaluation of oncolytic adenovirus replication in vivo.

Guse K, Dias JD, Bauerschmitz GJ, Hakkarainen T, Aavik E, Ranki T, Pisto T, Särkioja M, Desmond RA, Kanerva A, Hemminki A. Guse K, et al. Among authors: hemminki a. Gene Ther. 2007 Jun;14(11):902-11. doi: 10.1038/sj.gt.3302949. Epub 2007 Mar 22. Gene Ther. 2007. PMID: 17377596

4

Human mesenchymal stem cells lack tumor tropism but enhance the antitumor activity of oncolytic adenoviruses in orthotopic lung and breast tumors.

Hakkarainen T, Särkioja M, Lehenkari P, Miettinen S, Ylikomi T, Suuronen R, Desmond RA, Kanerva A, Hemminki A. Hakkarainen T, et al. Among authors: hemminki a. Hum Gene Ther. 2007 Jul;18(7):627-41. doi: 10.1089/hum.2007.034. Hum Gene Ther. 2007. PMID: 17604566

5

Treatment of metastatic renal cancer with capsid-modified oncolytic adenoviruses.

Guse K, Ranki T, Ala-Opas M, Bono P, Särkioja M, Rajecki M, Kanerva A, Hakkarainen T, Hemminki A. Guse K, et al. Among authors: hemminki a. Mol Cancer Ther. 2007 Oct;6(10):2728-36. doi: 10.1158/1535-7163.MCT-07-0176. Mol Cancer Ther. 2007. PMID: 17938266

6

Oncolytic adenovirus Ad5/3-delta24 and chemotherapy for treatment of orthotopic ovarian cancer.

Raki M, Särkioja M, Desmond RA, Chen DT, Bützow R, Hemminki A, Kanerva A. Raki M, et al. Among authors: hemminki a. Gynecol Oncol. 2008 Jan;108(1):166-72. doi: 10.1016/j.ygyno.2007.09.013. Epub 2007 Oct 22. Gynecol Oncol. 2008. PMID: 17950450

7

Cancer, stem cells, and oncolytic viruses.

Ribacka C, Pesonen S, Hemminki A. Ribacka C, et al. Among authors: hemminki a. Ann Med. 2008;40(7):496-505. doi: 10.1080/07853890802021342. Ann Med. 2008. PMID: 18608120 Review.

8

Systemic therapy for cervical cancer with potentially regulatable oncolytic adenoviruses.

Kanerva A, Lavilla-Alonso S, Raki M, Kangasniemi L, Bauerschmitz GJ, Takayama K, Ristimäki A, Desmond RA, Hemminki A. Kanerva A, et al. Among authors: hemminki a. PLoS One. 2008 Aug 13;3(8):e2917. doi: 10.1371/journal.pone.0002917. PLoS One. 2008. PMID: 18698374 Free PMC article.

9

Ad5/3-9HIF-Delta24-VEGFR-1-Ig, an infectivity enhanced, dual-targeted and antiangiogenic oncolytic adenovirus for kidney cancer treatment.

Guse K, Diaconu I, Rajecki M, Sloniecka M, Hakkarainen T, Ristimäki A, Kanerva A, Pesonen S, Hemminki A. Guse K, et al. Among authors: hemminki a. Gene Ther. 2009 Aug;16(8):1009-20. doi: 10.1038/gt.2009.56. Epub 2009 May 14. Gene Ther. 2009. PMID: 19440223

10

Mre11 inhibition by oncolytic adenovirus associates with autophagy and underlies synergy with ionizing radiation.

Rajecki M, af Hällström T, Hakkarainen T, Nokisalmi P, Hautaniemi S, Nieminen AI, Tenhunen M, Rantanen V, Desmond RA, Chen DT, Guse K, Stenman UH, Gargini R, Kapanen M, Klefström J, Kanerva A, Pesonen S, Ahtiainen L, Hemminki A. Rajecki M, et al. Among authors: hemminki a. Int J Cancer. 2009 Nov 15;125(10):2441-9. doi: 10.1002/ijc.24608. Int J Cancer. 2009. PMID: 19672857 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

341 results

Search Page